Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03959852 · ClinicalTrials.gov registry record · Phase 4
Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain
A Phase 4 study, sponsored by Mercy Health Ohio.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT03959852 is a Phase 4 study that was terminated before completion, run by Mercy Health Ohio. The registered enrollment target is 6 participants.
The verdict
NCT03959852, a Phase 4 study, was terminated before completion, sponsored by Mercy Health Ohio.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the potential opioid-sparing effect associated with the novel combination of fentanyl and sub-dissociative ketamine in adult patients with moderate to severe pain in the emergency department.
Interventions
- DRUG Ketamine
- DRUG Fentanyl
- COMBINATION_PRODUCT Fentanyl and Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-11-18 |
| Est. Completion | 2020-06-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03959852
The ClinicalTrials.gov registry entry for NCT03959852 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Health Ohio, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketamine is the first listed.
NCT03959852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03959852 about?
NCT03959852 is a clinical study titled "Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain". The objective of this study is to evaluate the potential opioid-sparing effect associated with the novel combination of fentanyl and sub-dissociative ketamine in adult patients with moderate to severe pain in the emergency department.
What is the current status of trial NCT03959852?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2019-11-18. Estimated completion is 2020-06-05.
What interventions are being tested in trial NCT03959852?
The interventions under investigation include: Ketamine (DRUG), Fentanyl (DRUG), Fentanyl and Ketamine (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03959852?
This trial is sponsored by Mercy Health Ohio, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.